The tweet was deleted by the author.
But we saved everything 🙂.
Brandon Beylo reports that Vertex Pharma has acquired Crinetics Pharma for a 100 percent premium to today's closing price.
He observes that merger and acquisition activity in the biotech sector is accelerating.
View post on X Loading...
Beylo has previously commented on market inflection points in other asset classes. In March, he suggested that gold could be nearing a bottom but might still drop to $3,800 per ounce before recovering. He later questioned whether gold trading at $4,000 would be viewed as a rare opportunity in the future. These observations highlight his continued focus on significant market moves.